Brooktree Capital Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.08M | Buy |
4,925
+185
| +4% | +$40.5K | 0.7% | 21 |
|
|
2025
Q1 | $1.06M | Buy |
4,740
+154
| +3% | +$34.5K | 0.8% | 19 |
|
|
2024
Q4 | $1.5M | Sell |
4,586
-18
| -0.4% | -$5.9K | 1.11% | 18 |
|
|
2024
Q3 | $1.38M | Buy |
4,604
+139
| +3% | +$41.7K | 1.12% | 20 |
|
|
2024
Q2 | $1.47M | Sell |
4,465
-198
| -4% | -$65.2K | 1.26% | 19 |
|
|
2024
Q1 | $1.85M | Buy |
4,663
+187
| +4% | +$74K | 1.42% | 19 |
|
|
2023
Q4 | $1.58M | Sell |
4,476
-265
| -6% | -$93.3K | 1.27% | 20 |
|
|
2023
Q3 | $1.78M | Buy |
4,741
+141
| +3% | +$52.9K | 1.49% | 20 |
|
|
2023
Q2 | $1.76M | Sell |
4,600
-400
| -8% | -$153K | 1.34% | 19 |
|
|
2023
Q1 | $1.73M | Buy |
5,000
+788
| +19% | +$273K | 1.35% | 18 |
|
|
2022
Q4 | $991K | Buy |
4,212
+68
| +2% | +$16K | 0.81% | 22 |
|
|
2022
Q3 | $1.02M | Buy |
4,144
+384
| +10% | +$94.5K | 0.84% | 24 |
|
|
2022
Q2 | $1.14M | Buy |
3,760
+615
| +20% | +$186K | 0.85% | 24 |
|
|
2022
Q1 | $1.29M | Buy |
+3,145
| New | +$1.29M | 0.84% | 25 |
|